Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: doxorubicinhydrochloride, Lapatinib
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Collaborators: GlaxoSmithKline